AbbVie
AbbVie Inc. is a prominent biopharmaceutical company based in the United States that was publicly traded and established in 2013. The company's inception stemmed from its spin-off from the renowned Abbott Laboratories.
Background[edit]
AbbVie's establishment in 2013 was a strategic move by Abbott Laboratories to separate its research-driven pharmaceutical business from its diversified medical products. The decision to spin off AbbVie aimed at allowing both entities to focus more exclusively on their individual business strategies and growth potentials.
Core Areas of Focus[edit]
AbbVie is committed to harnessing groundbreaking science to tackle some of the world's most complex and critical health challenges. Its primary areas of therapeutic focus include:
The company consistently invests in robust R&D initiatives to propel the boundaries of medicine and offer promising treatment avenues.
Notable Products[edit]
-6391.jpg)
AbbVie's portfolio boasts several groundbreaking and life-transforming drugs. Some of its flagship products include:
- Humira - An anti-inflammatory drug used for various conditions such as rheumatoid arthritis, psoriasis, and Crohn’s disease.
- Imbruvica - An oral, once-daily therapy mainly for patients with specific types of leukemia and lymphoma.
- Viekira Pak - A drug regimen used for the treatment of hepatitis C.
Global Presence[edit]
With a commitment to addressing complex health challenges, AbbVie has expanded its reach across the globe. It conducts business in more than 75 countries, ensuring that its life-saving treatments are accessible to patients worldwide.
Corporate Social Responsibility[edit]
Driven by its mission to have a remarkable impact on people's lives, AbbVie is heavily invested in community-centric programs, sustainable business practices, and initiatives aimed at reducing its carbon footprint.
See Also[edit]
References[edit]
- [1] AbbVie's Official History. Accessible at: https://www.abbvie.com/our-story.html
- [2] AbbVie's Therapeutic Areas of Focus. Retrieved from: https://www.abbvie.com/therapeutic-focus.html
- [3] AbbVie's Global Operations. Referenced from: https://www.abbvie.com/global-operations.html
 | This medical article is a stub. You can help WikiMD by expanding the page. |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
